A program to educate and support middle and high school students about substance use
Official title: A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students
Run by Massachusetts General Hospital · NCT06115746 · Data updated 2026-11-12
This study is testing a new drug education program for middle and high school students who have broken school rules about substance use to see if it helps them make better choices about drugs.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 9 Years to 22 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | November 17, 2023 |
| Main results expected | July 31, 2028 |
| Study ends | July 31, 2028 |
| Registry record updated | October 30, 2025 |
| Trial ID | NCT06115746 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are middle and high school students who have violated school substance use policies within the past month.
✕Probably not a fit
Patients who have previously received inpatient or specialty substance use treatment may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of the iDECIDE curriculum, a novel drug education and diversion program, for middle and high school students who have recently violated school substance use policies. Approximately 300 participants will be randomly assigned to either the iDECIDE program or a waitlist control group, with the aim of improving their knowledge, attitudes, and behaviors regarding substance use. The program includes behavioral support and psychoeducation delivered through videoconference or in-person visits over a four-week period. Participants will be monitored for one year to assess the impact of the intervention on their substance use outcomes.
Why it matters
Potential benefit: If successful, this program could provide adolescents with the knowledge and skills to make healthier decisions regarding substance use, potentially reducing future substance-related issues.
How similar studies have gone: Other studies have shown success with similar educational and diversion programs for substance use, indicating potential for positive outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Currently enrolled in middle or high school; 2. Violated school substance use policy within approximately the past month at the time of screening; 3. Have a parent or legal guardian who is able and willing to provide written informed consent (if under the age of 18); 4. Competent and willing to provide written informed assent (if under the age of 18) or written informed consent (if age 18 or older); 5. Able to commit to 9 study visits over approximately one year; 6. Able to safely participate in the protocol and appropriate for outpatient level of care, in the opinion of the investigator; 7. Has access to a reliable internet connection and a device that can run Zoom; 8. Able to read and write comfortably in one of the languages spoken by study staff. Exclusion Criteria: 1. Ever received substance use treatment in an inpatient or specialty care setting; 2. Ever engaged in intravenous (IV) drug use; 3. Current daily use of alcohol, non-medical benzodiazepines, and/or opioid use.
Where it's running
-
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Randi M Schuster, PhD
- Email: rschuster@mgh.harvard.edu
- Phone: 6176436673
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Technology-assisted parenting intervention for adolescents in substance use treatment
This study tests a new program that helps parents of teens in substance use treatment learn better parenting skills through technology to see if it can help their kids stay sober after treatment.
-
iPAWS: Helping teens manage pain and risky behaviors after wisdom tooth removal
This program tests a short online intervention to help teens and their parents handle post-surgical pain and reduce risky behaviors after wisdom tooth extraction.
-
Returning to the Land intervention for families in a tribal community
This program tests a biodiverse outdoor intervention with a tribal community to help reduce caregiver substance use and support emotional/behavioral development in children ages 1–5, by engaging families where teens 14–19 participate.
-
Connecting incarcerated adults with virtual peer recovery coaches to support addiction care
This trial tests whether a virtual peer recovery coach program helps people in jail link to and stick with addiction treatment compared to standard care.
-
Screening and brief counseling for substance use in adult survivors of childhood cancer
This study tests whether a short, evidence-based substance-use screening plus a brief counseling session can be added into routine survivorship care for adult survivors of childhood cancer at St. Jude.
-
Host-led harm reduction for men who have sex with men who engage in chemsex in Bangkok
This project will try a host-led harm reduction approach to reduce substance-related, sexual, mental health, and legal harms among men who have sex with men who engage in chemsex in Bangkok.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.